Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer

Figure 2 Macrophage migration inhibitory factor protein expression levels in gastric cancer tissue and association with overall and disease-free patient survival rates. A, B: Overall (A) and disease-free (B) survival in patients with gastric cancer who had low expression levels of macrophage migration inhibitory factor (MIF) (n = 36) vs high expression (n = 81); C, D: Overall survival (C) and disease-free (D) survival in patients with gastric cancer lymph-node metastasis who had low expression levels of MIF (n = 20) vs those with a high expression levels of MIF (n = 73) and in those without lymphatic metastasis (n = 24).